Macrophage-derived MLKL in alcohol-associated liver disease: Regulation of phagocytosis

Xiaoqin Wu1, Xiude Fan1, Megan R McMullen1

  • 1Northern Ohio Alcohol Center , Department of Inflammation and Immunity , Cleveland Clinic , Cleveland , Ohio , USA.

Abstract

Insights

Myeloid MLKL restricts liver inflammation and injury in alcohol-associated liver disease by regulating macrophage phagocytosis and immune cell homeostasis.

Area of Science:

  • Hepatology
  • Immunology
  • Cell Biology

Background:

  • Mixed lineage kinase domain-like pseudokinase (MLKL) is a key effector of necroptosis and influences intracellular vesicle trafficking.
  • MLKL's role in alcohol-associated liver disease (ALD) is incompletely understood, as MLKL knockout mice show only partial protection from ethanol-induced liver injury.

Purpose of the Study:

  • To investigate the cell-specific functions of MLKL in ethanol-induced liver injury.
  • To determine whether myeloid or non-myeloid MLKL contributes to ALD pathogenesis.

Main Methods:

  • Bone marrow transplantation between MLKL knockout and wild-type mice in a Gao-binge ALD model.
  • Assessment of hepatic injury, steatosis, inflammation, and bacterial burden.
  • Analysis of MLKL localization and function in macrophages (Kupffer cells and monocytes) in vitro and in vivo.

Main Results:

  • MLKL deficiency in myeloid cells exacerbated ethanol-induced liver injury, steatosis, and inflammation.
  • Myeloid MLKL deficiency led to increased bacterial burden and immune cell accumulation in the liver.
  • MLKL deficiency impaired the phagocytic capacity of Kupffer cells and monocytes, affecting intracellular trafficking to phagosomes and lysosomes.
  • In vivo studies confirmed reduced bioparticle uptake by Kupffer cells in MLKL knockout mice.

Conclusions:

  • Myeloid MLKL plays a critical protective role in restricting ethanol-induced liver inflammation and injury.
  • MLKL regulates hepatic immune cell homeostasis and macrophage phagocytosis, crucial mechanisms in ALD.